Belmetec Plus Tablet 20/12.5 Milligrams

Adult dose

This medication's dose should be adjusted with either Olmesartan Medoxomil or Hydrochlorothiazide alone, and if blood pressure is not adequately controlled, one tablet should be administered once a day regardless of meals. The dose should be adjusted considering the patient’s blood pressure response at intervals of 2 to 4 weeks. Elderly patients should start with the lowest dose and adjust according to kidney function, heart function, comorbid conditions, and concomitant medications.

Child dose

The safety and efficacy for children have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients allergic to the components in this medication or those with hypersensitivity to specific diuretics, severe kidney or liver dysfunction, pregnant or breastfeeding women should not take this medication. Patients with reduced blood volume, decreased kidney function, liver diseases, or specific heart conditions must exercise caution while taking this medication and require close monitoring by healthcare professionals. During the use of this medication, dizziness or hypotension may occur; if symptoms arise, one should lie down and rest and receive intravenous treatment if necessary. This medication can cause an imbalance of electrolytes in the blood, hence regular blood tests should be conducted to monitor potassium, sodium, and other levels. Particularly, this medication may make the skin sensitive to sunlight, so exposure to sunlight should be minimized, and any suspicious skin changes should be promptly discussed with a healthcare provider. Interactions with other medications may occur while taking this medication; therefore, patients must inform their healthcare provider of any other medications they are taking. Dizziness or drowsiness may be experienced, necessitating caution when driving or operating dangerous machinery. Women who are pregnant, planning to become pregnant, or breastfeeding should definitely consult with their healthcare provider before deciding to take this medication, and if necessary, should discontinue the medication or breastfeeding. The safety of this medication has not been established in children, so it is advisable not to administer it to children. Elderly patients may have reduced kidney or liver function; thus, they should start with the lowest dose and proceed with caution. In case of overdose, symptoms like hypotension and cardiac variations may occur, so immediate medical attention is necessary.

Serious side effects

• Hives, severe swelling (edema), angioedema, anaphylactic reaction, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction
• Severe rash with high fever, blisters, skin peeling, mucosal pain in mouth/eyes, severe skin adverse reactions
• Difficulty breathing or breathing problems, asthma attacks, breathing difficulty with cough and fever
• Yellowing of the skin or eyes (jaundice), severe lethargy, liver abnormalities (jaundice)

Mild side effects

Nausea, metabolic abnormalities (hyperuricemia, hyperglycemia, hyperlipidemia), dizziness, upper respiratory infection, headache, urinary tract infection, chest pain, back pain, peripheral edema, abdominal pain, dyspepsia, gastroenteritis, diarrhea, increased AST, increased GGT, increased ALT, elevated creatine phosphokinase, arthritis, arthralgia, myalgia, cough, rash, hematuria, weakness, vomiting, hair loss, itching, hives, increased blood pressure, nasal bleeding, asthma, palpitations

This medication should be stored in a sealed container to protect it from air and moisture and stored at room temperature between 1 to 25 degrees Celsius. Proper storage ensures the medication’s effectiveness is maintained and prevents degradation.

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets/bottle